Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2023

May 15, 2023

BUY
$87.74 - $117.27 $1.75 Million - $2.35 Million
20,000 Added 200.0%
30,000 $2.92 Million
Q2 2022

Aug 12, 2022

BUY
$71.48 - $86.85 $714,800 - $868,500
10,000 New
10,000 $829,000
Q2 2020

Aug 13, 2020

SELL
$79.55 - $124.22 $2.43 Million - $3.8 Million
-30,600 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$71.37 - $96.85 $742,248 - $1.01 Million
-10,400 Reduced 25.37%
30,600 $2.59 Million
Q4 2019

Feb 14, 2020

BUY
$64.27 - $86.37 $899,780 - $1.21 Million
14,000 Added 51.85%
41,000 $3.47 Million
Q3 2019

Nov 12, 2019

BUY
$67.4 - $85.11 $404,400 - $510,660
6,000 Added 28.57%
27,000 $1.82 Million
Q2 2019

Aug 14, 2019

SELL
$80.35 - $93.9 $522,274 - $610,350
-6,500 Reduced 23.64%
21,000 $1.8 Million
Q1 2019

May 14, 2019

BUY
$84.2 - $98.62 $2.32 Million - $2.71 Million
27,500 New
27,500 $2.44 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Dld Asset Management, LP Portfolio

Follow Dld Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Dld Asset Management, LP with notifications on news.